Aksjekurser for og nyheter om Silence Therapeutics PLC - ADR (SLN) – Google Finance

Finance

StartsideSLN • NASDAQ

Silence Therapeutics PLC - ADR

5,60 $

22. jan., 11:54:25 GMT-5 · USD · NASDAQ · Ansvarsfraskrivelse

Nuvalent Inc

110,96 $

NUVL1,76 %

Viking Therapeutics Inc

33,82 $

VKTX1,32 %

Biomarin Pharmaceutical Inc

57,20 $

BMRN0,75 %

Legend Biotech Corp

19,74 $

LEGN4,91 %

Insmed Inc

157,25 $

INSM0,59 %

Immutep Ltd

0,42 $

IMM1,22 %

Arcellx Inc

67,40 $

ACLX2,13 %

Mereo BioPharma Group plc - ADR

0,52 $

MREO1,43 %

Rocket Pharmaceuticals Inc

3,86 $

RCKT4,57 %

Cabaletta Bio Inc

3,02 $

CABA29,06 %

AksjeVerdipapir notert i USA

Forrige sluttkurs

5,68 $

Dagsintervall

5,50 $ - 5,74 $

Årsintervall

1,97 $ - 7,78 $

Markedsverdi

265,45 mill. USD

Gjennomsnittlig volum

336,65k

P/E-tall

-

Utbytte

-

Hovedbørs

NASDAQ

Markedsnyheter

for 2 døgn siden

Wall Street faller kraftig fra start

Dagens Næringsliv

for 11 timer siden

Wall Street tror på tek – i pluss fra start

for 19 minutter siden

Heritage Financial (NASDAQ:HFWA) Sets New 12-Month High on Earnings Beat

San Antonio Express-News

for 33 minutter siden

US stocks climb again after Trump calls off his tariffs for Greenland

for 24 minutter siden

MKDWELL Tech to Implement 30-for-1 Share Combination to Support Nasdaq Compliance

for 3 timer siden

Wall Street’s Texas move gains steam as NYSE Texas hits 100-company milestone

Om

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia

Administrerende direktør

Craig A Tooman

Grunnlagt

1994

Nettsted

silence-therapeutics.com

Ansatte

116

Søk

Slett søket

Lukk søkefunksjonen

Google-apper

Hovedmeny